The consequences are deepening for San Francisco-based concierge health care provider One Medical following an NPR investigation that found the company administered COVID-19 vaccinations to those with connections to leadership, as well as ineligible patients.
The House Select Subcommittee on the Coronavirus Crisis is launching its own investigation into the company’s practices, NPR has learned. The probe has plunged the publicly traded company, whose business model depends on patients paying a $199 annual fee for VIP health care services, into damage control mode.
“Despite being warned that the company’s lax oversight of vaccine eligibility rules was allowing ineligible patients to jump the line, One Medical has reportedly failed to properly implement an effective protocol to verify eligibility and instructed staff not to police eligibility,” wrote subcommittee Chairman James Clyburn, D-South Carolina, in a letter sent to One Medical late Monday night.
Clyburn cited multiple news reports, including NPR’s investigation, to denounce One Medical’s “irresponsible practices,” adding that “prioritizing the vaccination of Americans who are at higher risk from the coronavirus is critical to saving lives and controlling the pandemic.”
The letter demands documents and information on One Medical’s COVID-19 vaccination practices within two weeks, with a deadline of March 15. Among other topics, it seeks demographic breakdowns of COVID-19 vaccines administered to date and communications related to vaccination appointments arranged for those close to the company’s executives.